Shuaikang Chang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Plasmon-Driven Light Absorption and Hole Extraction in Efficient Tin-Based Perovskite Solar Cells.

Plasmon-Driven Light Absorption and Hole Extraction in Efficient Tin-Based Perovskite Solar Cells.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: March 02, 2026

Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy.

Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy.

Journal: Journal for immunotherapy of cancer

Published: February 15, 2026

Quaternary Ammonium Additives Enable Efficient and Stable 1.77 eV Wide-Bandgap Perovskite Solar Cells.

Quaternary Ammonium Additives Enable Efficient and Stable 1.77 eV Wide-Bandgap Perovskite Solar Cells.

Journal: Chemistry, an Asian journal

Published: January 31, 2026

Mixed-ligand ZIF-doped perovskite films toward damp-heat-stable solar cells.

Mixed-ligand ZIF-doped perovskite films toward damp-heat-stable solar cells.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: December 05, 2025

Editor's Note: A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.

Editor's Note: A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.

Journal: Cancer research

Published: June 27, 2025

METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.

METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.

Journal: Oncogene

Published: June 23, 2025

EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.

EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.

Journal: Acta biochimica et biophysica Sinica

Published: May 28, 2024

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.

Journal: Acta biochimica et biophysica Sinica

Published: November 27, 2023

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.

Journal: Journal of translational medicine

Published: September 21, 2023

TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage.

TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage.

Journal: Cancer medicine

Published: May 29, 2023

Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis.

Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis.

Journal: Immunity, inflammation and disease

Published: April 07, 2023

Correction to: Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress.

Correction to: Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress.

Journal: Cell death & disease

Published: March 06, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026